JANIK, Adrianna, Maria TORRENTE, Luca COSTABELLO, Virginia CALVO, Brian WALSH, Carlos CAMPS, Sameh K MOHAMED, Ana L ORTEGA, Vít NOVÁČEK, Bartomeu MASSUTÍ, Pasquale MINERVINI, M Rosario GARCIA CAMPELO, Edel del BARCO, Joaquim BOSCH-BARRERA, Ernestina MENASALVAS, Mohan TIMILSINA and Mariano PROVENCIO. Machine Learning–Assisted Recurrence Prediction for Patients With Early-Stage Non–Small-Cell Lung Cancer. JCO CLINICAL CANCER INFORMATICS. UNITED STATES: LIPPINCOTT WILLIAMS & WILKINS, 2023, vol. 7, e2200062, p. 1-11. ISSN 2473-4276. Available from: https://dx.doi.org/10.1200/CCI.22.00062.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Machine Learning–Assisted Recurrence Prediction for Patients With Early-Stage Non–Small-Cell Lung Cancer
Authors JANIK, Adrianna (guarantor), Maria TORRENTE, Luca COSTABELLO, Virginia CALVO, Brian WALSH, Carlos CAMPS, Sameh K MOHAMED, Ana L ORTEGA, Vít NOVÁČEK (203 Czech Republic, belonging to the institution), Bartomeu MASSUTÍ, Pasquale MINERVINI, M Rosario GARCIA CAMPELO, Edel del BARCO, Joaquim BOSCH-BARRERA, Ernestina MENASALVAS, Mohan TIMILSINA and Mariano PROVENCIO.
Edition JCO CLINICAL CANCER INFORMATICS, UNITED STATES, LIPPINCOTT WILLIAMS & WILKINS, 2023, 2473-4276.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10201 Computer sciences, information science, bioinformatics
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.200 in 2022
RIV identification code RIV/00216224:14330/23:00131337
Organization unit Faculty of Informatics
Doi http://dx.doi.org/10.1200/CCI.22.00062
UT WoS 001133302300003
Keywords (in Czech) relapse prediction, machine learning, explainability, health informatics, lung cancer
Keywords in English relapse prediction; machine learning; explainability; health informatics; lung cancer
Tags Artificial Intelligence, machine learning, medical informatics
Tags International impact, Reviewed
Changed by Changed by: RNDr. Pavel Šmerk, Ph.D., učo 3880. Changed: 10/4/2024 10:40.
Abstract
PURPOSE Stratifying patients with cancer according to risk of relapse can personalize their care. In this work, we provide an answer to the following research question: How to use machine learning to estimate probability of relapse in patients with early-stage non–small-cell lung cancer (NSCLC)? MATERIALS AND METHODS For predicting relapse in 1,387 patients with early-stage (I-II) NSCLC from the Spanish Lung Cancer Group data (average age 65.7 years, female 24.8%, male 75.2%), we train tabular and graph machine learning models. We generate automatic explanations for the predictions of such models. For models trained on tabular data, we adopt SHapley Additive exPlanations local explanations to gauge how each patient feature contributes to the predicted outcome. We explain graph machine learning predictions with an example-based method that highlights influential past patients. RESULTS Machine learning models trained on tabular data exhibit a 76% accuracy for the random forest model at predicting relapse evaluated with a 10-fold cross-validation (the model was trained 10 times with different independent sets of patients in test, train, and validation sets, and the reported metrics are averaged over these 10 test sets). Graph machine learning reaches 68% accuracy over a held-out test set of 200 patients, calibrated on a held-out set of 100 patients. CONCLUSION Our results show that machine learning models trained on tabular and graph data can enable objective, personalized, and reproducible prediction of relapse and, therefore, disease outcome in patients with early-stage NSCLC. With further prospective and multisite validation, and additional radiological and molecular data, this prognostic model could potentially serve as a predictive decision support tool for deciding the use of adjuvant treatments in early-stage lung cancer.
Links
MUNI/G/1763/2020, interní kód MUName: AIcope - AI support for Clinical Oncology and Patient Empowerment (Acronym: AIcope)
Investor: Masaryk University, INTERDISCIPLINARY - Interdisciplinary research projects
PrintDisplayed: 1/5/2024 12:56